Ketones are water-soluble organic molecules produced mainly in the liver from fatty acids during periods when carbohydrate availability is low or insulin signaling is reduced. The principal circulating ketone bodies are beta-hydroxybutyrate (BHB), acetoacetate (AcAc), and acetone (a byproduct). In physiologic “fuel switching,” ketone production rises after fasting, prolonged exercise, ketogenic diets, or low-carbohydrate intake, enabling tissues—including the brain, heart, and skeletal muscle—to access an alternative energy substrate. While popular narratives sometimes contrast ketones with “glucose,” clinically the more precise concept is metabolic flexibility: the coordinated ability to shift between carbohydrate oxidation and fat-derived ketone utilization depending on hormonal and substrate conditions.
From a mechanistic standpoint, ketogenesis is regulated by the balance between insulin and counter-regulatory hormones such as glucagon, catecholamines, and cortisol. Low insulin states promote lipolysis in adipose tissue, increasing free fatty acids delivered to the liver. Hepatic beta-oxidation yields acetyl-CoA, which then drives ketone body synthesis via mitochondrial pathways. Ketone utilization occurs in peripheral tissues through transporters and enzymatic conversion: AcAc is activated to AcAc-CoA, and BHB is converted to AcAc in mitochondria before entering the TCA cycle as acetyl-CoA. Importantly, the brain’s uptake and use of BHB is a key reason ketone metabolism supports survival during prolonged fasting.
Clinically, ketones are central to several contexts. First, nutritional ketosis occurs when carbohydrate intake is sufficiently restricted to raise ketone levels without causing marked acidemia. Typical blood BHB ranges vary by diet and individual response; however, the hallmark of nutritional ketosis is that compensatory mechanisms maintain acid-base balance. Second, there is pathologic ketosis or ketoacidosis, most notably diabetic ketoacidosis (DKA), where insulin deficiency leads to excessive ketone production and metabolic acidosis. DKA is characterized by hyperglycemia (often, but not always), high anion-gap metabolic acidosis, dehydration, and ketonemia/ketonuria. A related entity is euglycemic ketoacidosis (seen with reduced carbohydrate intake, prolonged fasting, vomiting, pregnancy, or certain medications such as SGLT2 inhibitors), where glucose levels may be only mildly elevated while ketones and acidosis remain clinically dangerous.
A key safety concept is that ketones themselves are not inherently harmful in physiologic ranges, but the conditions that produce very high ketones—particularly insulin deficiency, dehydration, and impaired buffering—can precipitate acid-base derangements. Risk stratification therefore focuses on the underlying cause, not solely the presence of ketones. Symptoms warranting urgent evaluation include nausea/vomiting, abdominal pain, rapid or deep breathing (Kussmaul respirations), altered mental status, severe fatigue, and signs of dehydration. Laboratory confirmation involves measurement of serum ketones (preferably BHB), blood gas or serum bicarbonate, anion gap calculation, electrolytes, and glucose.
In metabolic medicine, exogenous or dietary induction of ketosis has been studied for epilepsy (ketogenic diet in refractory seizures), certain neurodegenerative conditions, weight management, and type 2 diabetes with careful monitoring. Proposed benefits include reduced insulin levels, altered hepatic glucose output, shifts in mitochondrial energy flux, and changes in signaling pathways such as oxidative stress responses and neurotransmitter metabolism. For example, in epilepsy, ketone metabolism correlates with seizure threshold changes, though the exact causal mechanisms remain incompletely understood and likely involve multiple pathways rather than a single “ketone effect.”
Interpretation of ketone values requires nuance. Urine ketones largely reflect acetoacetate and can lag behind dynamic serum changes; blood BHB provides a more direct measure of active ketone status. Additionally, individual variability is substantial due to differences in insulin sensitivity, dietary adherence, baseline glycogen stores, and renal clearance. Overemphasis on a single number can lead to mismanagement; clinicians integrate ketone trends with clinical status, hydration, acid-base markers, and medication context.
A practical clinical question is how to distinguish benign nutritional ketosis from impending ketoacidosis. The presence of systemic toxicity, significant metabolic acidosis, elevated anion gap, and concurrent insulin deficiency point toward pathology. In contrast, stable patients without dehydration, with normal vital signs or mild diet-related symptoms (e.g., transient “keto flu”), and without bicarbonate/anion gap abnormalities are more consistent with nutritional ketosis. Even in “safe” contexts, monitoring is important for people with diabetes, chronic kidney disease, pregnancy, and those taking agents that predispose to euglycemic states.
In summary, ketone metabolism is a normal, hormonally regulated energy pathway that supports fasting survival and provides fuel when glucose availability is limited. The medical relevance lies not in a simplistic opposition to glucose, but in the conditions that determine metabolic flexibility versus dangerous ketone-driven acidemia. Evidence-based use of ketone-inducing strategies requires attention to mechanism, monitoring, and individualized risk to prevent rare but serious outcomes such as DKA and euglycemic ketoacidosis.
Source: @GlucoseNot
Ketones Not Glucose: GDP is fake power. Real edge in US-China rivalry = discretionary fiscal capacity. Debt interest, entitlements & aging are crushing it. #BSV fixes friction: real-time tax transparency, cut waste, tokenized sovereign debt. Stretch budgets further.. #breaking
— @GlucoseNot May 1, 2026
SHOP AMAZON BEST SELLERS, CLICK TO BUY FROM AMAZON.
SHOP AMAZON BEST SELLERS, CLICK TO BUY FROM AMAZON.
